Artificial Disc Replacement Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Artificial Disc Replacement Systems Pipeline Market Report Overview

Artificial disc replacement offers an alternative to spinal fusion for the patients who have chronic back pain from degenerative disc disease. It allows natural motion in the part of the spine where the disc is implanted and thus allows for an early return to function. The implant is designed so that it can withstand bending, compression and repeated loads during movement.

The artificial disc replacement systems pipeline market research report covers comprehensive information about the pipeline products with their comparative analysis at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Segments ·       Lumbar Total Disc Replacement Systems

·       Cervical Total Disc Replacement Systems

Key Territories ·       The US

·       Europe

·       China

·       Brazil

·       Russia

Key Regulatory Paths ·       PMA

·       510(k)

·       CE

·       NMPA

·       ANVISA

Leading Companies ·       AxioMed Spine Corp

·       C.I.Takiron Corp

·       City, University of London

·       Highridge Medical Inc

·       Medical University of South Carolina

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Artificial Disc Replacement Systems Pipeline Market Segments

The key segments in the artificial disc replacement systems pipeline market are lumbar total disc replacement systems and cervical total disc replacement systems. As of October 2024, lumbar total disc replacement systems accounted for the highest number of pipeline products.

Artificial Disc Replacement Systems Pipeline Market Analysis by Segments, 2024 (%)

Artificial Disc Replacement Systems Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segmental Insights into the Artificial Disc Replacement Systems Pipeline Market

Download a Free Report Sample

Artificial Disc Replacement Systems Pipeline Market Segmentation by Territories

The key territories in the artificial disc replacement systems pipeline market are the US, Europe, China, Brazil, and Russia, among others. As of October 2024, the US accounts for the highest number of pipeline products.

Artificial Disc Replacement Systems Pipeline Market Analysis by Territories, 2024 (%)

Artificial Disc Replacement Systems Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Artificial Disc Replacement Systems Pipeline Market

Download a Free Report Sample

Artificial Disc Replacement Systems Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the artificial disc replacement systems pipeline products market are PMA,510(k), CE, NMPA, and ANVISA. As of October 2024, PMA is the most followed pathway for pipeline products in the artificial disc replacement systems market.

Artificial Disc Replacement Systems Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Artificial Disc Replacement Systems Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Artificial Disc Replacement Systems Pipeline Market

Download a Free Report Sample

Artificial Disc Replacement Systems Pipeline Market – Competitive Landscape

A few of the leading companies associated with the artificial disc replacement systems pipeline market are:

  • AxioMed Spine Corp
  • I.Takiron Corp
  • City, University of London
  • Highridge Medical Inc
  • Medical University of South Carolina

AxioMed Spine Corp: Headquartered in Garfield Heights, Ohio, the US, AxioMed Spine Corp (AxioMed) is a medical device company that develops spinal disc replacement products for patients with degenerative spine disease. It also develops spinal implants including early artificial disc development efforts. The company’s freedom lumbar disc is a disc replacement device, that is used in the treatment of single-level symptomatic lumbar degenerative disc disease. Its Freedom cervical disc is a total disc replacement device, which is used to relieve neck pain. The company sells its products through its distributors in domestic and international markets.

C.I. Takiron Corp: Headquartered in Minato-ku, Tokyo, Japan, C.I. Takiron Corp (C.I. Takiron), a subsidiary of Itochu Corp,  is a diversified manufacturing company with a focus on synthetic resin products, inorganic chemical industrial products, and electrical and metal materials, among others. The company’s product portfolio includes building materials, lighting equipment, plumbing and flooring materials, among others. Takiron also produces functional films like shrink film and zipper tape. These products find applications across various industries including construction, electronics, agriculture, and packaging.

Artificial Disc Replacement Systems Pipeline Market Analysis by Companies, 2024

Artificial Disc Replacement Systems Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Artificial Disc Replacement Systems Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Artificial Disc Replacement Systems Pipeline Market Segments Outlook (2024)

  • Lumbar Total Disc Replacement Systems
  • Cervical Total Disc Replacement Systems

Artificial Disc Replacement Systems Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Brazil
  • Russia

Artificial Disc Replacement Systems Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • 510(k)
  • CE
  • NMPA
  • ANVISA

Scope

This report provides:

  • An extensive coverage of the artificial disc replacement systems under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of artificial disc replacement systems and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of artificial disc replacement systems under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

ALCeraX Medizintechnik GmbH
Articulus Bio LLC
AxioMed Spine Corp
Baxano Surgical Inc (Inactive)
Beijing Aikang Yicheng Medical Equipment Co Ltd
C.I. Takiron Corp
City, University of London
Disc Motion Technologies (Inactive)
Highridge Medical Inc
Integra Spine
Medical University of South Carolina
Meliora Medical BV
MiMedx Group Inc
Mimesis Spine BV
NEXUS TDR Inc
Precision Spine Inc
RE Spine, LLC
SeaSpine, Inc.
SINTX Technologies Inc
Smart Disc Inc
SpinalMotion Inc
Spineart Geneva SA
SpineSmith Holdings LLC
Synergy Disc Replacement, Inc.
Synergy Spine Solutions Inc
TrueMotion Spine, Inc.
University of South Florida
Weill Cornell Medical College

Table of Contents

  • 1. Table of Contents

    • 1.1. List of Tables
    • 1.2. List of Figures

  • 2. Introduction

    • 2.1. Artificial Disc Replacement Systems Overview

  • 3. Products under Development

    • 3.1. Artificial Disc Replacement Systems – Pipeline Products by Stage of Development
    • 3.2. Artificial Disc Replacement Systems – Pipeline Products by Segment
    • 3.3. Artificial Disc Replacement Systems – Pipeline Products by Territory
    • 3.4. Artificial Disc Replacement Systems – Pipeline Products by Regulatory Path
    • 3.5. Artificial Disc Replacement Systems – Pipeline Products by Estimated Approval Date
    • 3.6. Artificial Disc Replacement Systems – Ongoing Clinical Trials

  • 4. Artificial Disc Replacement Systems – Pipeline Products under Development by Companies

    • 4.1. Artificial Disc Replacement Systems Companies – Pipeline Products by Stage of Development
    • 4.2. Artificial Disc Replacement Systems – Pipeline Products by Stage of Development

  • 5. Artificial Disc Replacement Systems Companies and Product Overview

    • 5.1. ALCeraX Medizintechnik GmbH Company Overview

      • 5.1.1. ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2. Articulus Bio LLC Company Overview

      • 5.2.1. Articulus Bio LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3. AxioMed Spine Corp Company Overview

      • 5.3.1. AxioMed Spine Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4. Baxano Surgical Inc (Inactive) Company Overview

      • 5.4.1. Baxano Surgical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5. Beijing Aikang Yicheng Medical Equipment Co Ltd Company Overview

      • 5.5.1. Beijing Aikang Yicheng Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6. C.I. Takiron Corp Company Overview

      • 5.6.1. C.I. Takiron Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7. City, University of London Company Overview

      • 5.7.1. City, University of London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8. Disc Motion Technologies (Inactive) Company Overview

      • 5.8.1. Disc Motion Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9. Highridge Medical Inc Company Overview

      • 5.9.1. Highridge Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10. Integra Spine Company Overview

      • 5.10.1. Integra Spine Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11. Medical University of South Carolina Company Overview

      • 5.11.1. Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12. Meliora Medical BV Company Overview

      • 5.12.1. Meliora Medical BV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13. MiMedx Group Inc Company Overview

      • 5.13.1. MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14. Mimesis Spine BV Company Overview

      • 5.14.1. Mimesis Spine BV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15. NEXUS TDR Inc Company Overview

      • 5.15.1. NEXUS TDR Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16. Precision Spine Inc Company Overview

      • 5.16.1. Precision Spine Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17. RE Spine, LLC Company Overview

      • 5.17.1. RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18. SeaSpine, Inc. Company Overview

      • 5.18.1. SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19. SINTX Technologies Inc Company Overview

      • 5.19.1. SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20. Smart Disc Inc Company Overview

      • 5.20.1. Smart Disc Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21. SpinalMotion Inc Company Overview

      • 5.21.1. SpinalMotion Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22. Spineart Geneva SA Company Overview

      • 5.22.1. Spineart Geneva SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23. SpineSmith Holdings LLC Company Overview

      • 5.23.1. SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24. Synergy Disc Replacement, Inc. Company Overview

      • 5.24.1. Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25. Synergy Spine Solutions Inc Company Overview

      • 5.25.1. Synergy Spine Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26. TrueMotion Spine, Inc. Company Overview

      • 5.26.1. TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27. University of South Florida Company Overview

      • 5.27.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28. Weill Cornell Medical College Company Overview

      • 5.28.1. Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

  • 6. Artificial Disc Replacement Systems- Recent Developments

    • 6.1. Oct 15, 2024: Globus Medical Schedules Third Quarter Earnings Release and Conference Call
    • 6.2. Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
    • 6.3. Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
    • 6.4. Sep 26, 2024: Over 7,500 Procedures Completed in Two Years with Centinel Spine’s Prodisc C Vivo and Prodisc C SK Cervical Total Disc Replacement System Since U.S. Launch
    • 6.5. Sep 25, 2024: Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc 2-Level IDE clinical trial
    • 6.6. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
    • 6.7. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
    • 6.8. Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
    • 6.9. Jul 31, 2024: ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance
    • 6.10. Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
    • 6.11. Jul 10, 2024: ATEC to Report Second Quarter Financial Results on July 31, 2024
    • 6.12. Jul 09, 2024: Orthofix to Report Second Quarter 2024 Financial Results
    • 6.13. Jul 04, 2024: Spinal Kinetics Receives 510(K) Clearance For M6-C Disposable Instrument
    • 6.14. Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
    • 6.15. Jun 13, 2024: Medtronic Confirms Global Layoffs
    • 6.16. May 23, 2024: Newport News Spine Surgeon Performs First Two-Level Cervical Disc Arthroplasty in Hampton Roads
    • 6.17. Apr 23, 2024: Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
    • 6.18. Apr 16, 2024: Over 5,000 Procedures Completed in U.S. with Centinel Spine’s prodisc C Vivo and prodisc C SK Cervical Total Disc Replacement System
    • 6.19. Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • 6.20. Feb 29, 2024: Spineart Completes Enrollment in the Baguera C Ide Trial for Single-Level Cervical Disc Replacement
    • 6.21. Feb 21, 2024: Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
    • 6.22. Jan 09, 2024: Orthofix Medical Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
    • 6.23. Nov 29, 2023: Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
    • 6.24. Nov 28, 2023: Disc Surgery Center at Newport Beach Now Enrolling Patients in Clinical Study on Artificial Disc Replacement
    • 6.25. Nov 14, 2023: Largest Commercial Payers in Four States Expand Patient Access to Centinel Spine’s Prodisc L

  • 7. Appendix

    • 7.1. Methodology
    • 7.2. About GlobalData
    • 7.3. Contact Us
    • 7.4. Disclaimer

Table

Artificial Disc Replacement Systems – Pipeline Products by Stage of Development

Artificial Disc Replacement Systems – Pipeline Products by Segment

Artificial Disc Replacement Systems – Pipeline Products by Territory

Artificial Disc Replacement Systems – Pipeline Products by Regulatory Path

Artificial Disc Replacement Systems – Pipeline Products by Estimated Approval Date

Artificial Disc Replacement Systems – Ongoing Clinical Trials

Artificial Disc Replacement Systems Companies – Pipeline Products by Stage of Development

Artificial Disc Replacement Systems – Pipeline Products by Stage of Development

ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview

ConCera – Product Status

ConCera – Product Description

Articulus Bio LLC Pipeline Products & Ongoing Clinical Trials Overview

Cervical/Lumbar Spine Artificial Disc – Product Status

Cervical/Lumbar Spine Artificial Disc – Product Description

AxioMed Spine Corp Pipeline Products & Ongoing Clinical Trials Overview

Freedom Lateral Lumbar Disc – Product Status

Freedom Lateral Lumbar Disc – Product Description

Baxano Surgical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

TranS1 – Percutaneous Disc Replacement (PDR) – Product Status

TranS1 – Percutaneous Disc Replacement (PDR) – Product Description

Beijing Aikang Yicheng Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Cervical Artificial Intervertebral Disc – Product Status

Cervical Artificial Intervertebral Disc – Product Description

C.I. Takiron Corp Pipeline Products & Ongoing Clinical Trials Overview

FABRICUBE – Product Status

FABRICUBE – Product Description

City, University of London Pipeline Products & Ongoing Clinical Trials Overview

Artificial Intervertebral Disc Prosthesis – Product Status

Artificial Intervertebral Disc Prosthesis – Product Description

Disc Motion Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Inlign PL – Product Status

Inlign PL – Product Description

Highridge Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Min T Lumbar Artificial Disc – Product Status

Min T Lumbar Artificial Disc – Product Description

Rescue Cervical Disc – Product Status

Rescue Cervical Disc – Product Description

Integra Spine Pipeline Products & Ongoing Clinical Trials Overview

eDISC – Product Status

eDISC – Product Description

Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview

Artificial Intervertebral Disc – Product Status

Artificial Intervertebral Disc – Product Description

Meliora Medical BV Pipeline Products & Ongoing Clinical Trials Overview

Mimesis-C – Product Status

Mimesis-C – Product Description

Prosthetic Intervertebral Disc – Back Pain – Product Status

Prosthetic Intervertebral Disc – Back Pain – Product Description

MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview

SaluDisc – Product Status

SaluDisc – Product Description

Mimesis Spine BV Pipeline Products & Ongoing Clinical Trials Overview

Cervical Total Disc Replacement Device – Product Status

Cervical Total Disc Replacement Device – Product Description

NEXUS TDR Inc Pipeline Products & Ongoing Clinical Trials Overview

FlexBac – Product Status

FlexBac – Product Description

Precision Spine Inc Pipeline Products & Ongoing Clinical Trials Overview

Cervical Disc Replacement Device – Product Status

Cervical Disc Replacement Device – Product Description

RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview

Intervertebral Disc – Product Status

Intervertebral Disc – Product Description

SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Catalina – Product Status

Catalina – Product Description

La Jolla – Product Status

La Jolla – Product Description

SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Spartacus – Product Status

Spartacus – Product Description

Smart Disc Inc Pipeline Products & Ongoing Clinical Trials Overview

Spinal Replacement Disc – Product Status

Spinal Replacement Disc – Product Description

SpinalMotion Inc Pipeline Products & Ongoing Clinical Trials Overview

Kineflex Lumbar Disc – Product Status

Kineflex Lumbar Disc – Product Description

Spineart Geneva SA Pipeline Products & Ongoing Clinical Trials Overview

BAGUERA C Cervical Disc Prosthesis – Product Status

BAGUERA C Cervical Disc Prosthesis – Product Description

Spineart Geneva SA – Ongoing Clinical Trials Overview

BAGUERA C Cervical Disc Prosthesis – A Multicenter, Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of the BAGUERA C Cervical Disc Prosthesis to the Mobi-C Cervical Disc for the Treatment of Patients with Symptomatic Cervical Disc Disease at a Single Level

BAGUERA C Cervical Disc Prosthesis – A Multicenter, Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of the BAGUERA C Cervical Disc Prosthesis to the Mobi-C Cervical Disc for the Treatment of Patients with Symptomatic Cervical Disc Disease at Two Contiguous Levels

SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview

Biologically Active Artificial Disc – Product Status

Biologically Active Artificial Disc – Product Description

Cervical Disc – Product Status

Cervical Disc – Product Description

Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Synergy Disc – Product Status

Synergy Disc – Product Description

Synergy Disc Replacement, Inc. – Ongoing Clinical Trials Overview

Synergy Disc – A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc

Synergy Disc – A Multi-center, Prospective, Historically Controlled Pivotal Trial Comparing the Safety and Effectiveness of the Synergy Disc to Anterior Cervical Discectomy and Fusion in Patients with One-level Symptomatic Cervical Degenerative Disc Disease (DDD)

Synergy Disc – A Multi-Center, Prospective, Historically Controlled Pivotal Trial Comparing the Safety and Effectiveness of the Synergy Disc to Anterior Cervical Discectomy and Fusion in Patients with Two-Level Symptomatic Cervical Degenerative Disc Disease (DDD)

Synergy Disc – A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc

Synergy Disc – A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc

Synergy Disc – A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc

Synergy Spine Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

Artificial Cervical Disc Replacement Device – Product Status

Artificial Cervical Disc Replacement Device – Product Description

Synergy Spine Solutions Inc – Ongoing Clinical Trials Overview

Artificial Cervical Disc Replacement Device – Multi-centre Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc®

TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

TrueMotion Cervical D6 – Product Status

TrueMotion Cervical D6 – Product Description

TrueMotion Lumbar Device – Product Status

TrueMotion Lumbar Device – Product Description

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

Spine Disc Prosthesis – Product Status

Spine Disc Prosthesis – Product Description

Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

Biological Spinal Implant – Product Status

Biological Spinal Implant – Product Description

Glossary

Figures

Artificial Disc Replacement Systems – Pipeline Products by Stage of Development

Artificial Disc Replacement Systems – Pipeline Products by Segment

Artificial Disc Replacement Systems – Pipeline Products by Territory

Artificial Disc Replacement Systems – Pipeline Products by Regulatory Path

Artificial Disc Replacement Systems – Pipeline Products by Estimated Approval Date

Artificial Disc Replacement Systems – Ongoing Clinical Trials

Frequently asked questions

Artificial Disc Replacement Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Artificial Disc Replacement Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Artificial Disc Replacement Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Artificial Disc Replacement Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.